Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices

Claim 2

A synthetic heteropolymer comprising a single stranded nucleic acid molecule having at least a first and a second defined sequence segment, wherein the first defined sequence segment is capable of specifically and noncovalently binding to a first non-oligonucleotide molecule having a selected activity and the second defined sequence segment is capable of specifically and noncovalently binding to a second, different non-oligonucleotide molecule having a selected activity, wherein said first and second defined sequence segments are not known to be biological recognition sites for said first and second nonoligonucleotide molecules.

Claim 3

A synthetic heteropolymer comprising a single stranded nucleic acid molecule having at least a first and a second defined sequence segment, wherein the first defined sequence segment is not known to be a biological recognition site for nonoligonucleotide molecules and is capable of specifically and noncovalently binding to a non-oligonucleotide molecule having a selected activity and the second defined sequence segment is capable of hybridization to a selected nucleic acid sequence which does not hybridize to said first defined sequence segment, said first and second defined sequence segments bringing said nonoligonucleotide molecule and said nucleic acid sequence into proximity such that the binding or activity of said nonoligonucleotide molecule is modulated by binding of the selected nucleic acid sequence.

Claim 4

A synthetic heteropolymer comprising a single stranded nucleic acid molecule having at least a first and a second defined sequence segment, wherein the first defined sequence segment is not known to be a biological recognition site for nonoligonucleotide molecules and is capable of specifically and noncovalently binding to a non-oligonucleotide molecule having a selected activity and the second defined sequence segment is capable of hybridization to a selected nucleic acid sequence which does not hybridize to said first defined sequence segment, said first and second defined sequence segments bringing said nonoligonucleotide molecule and said nucleic acid sequence into proximity such that the binding or activity of said nonoligonucleotide molecule is modulated by binding of the selected nucleic acid sequence.

Claim 5

A multimolecular complex comprising a synthetic heteropolymer of claim 2 having a non-oligonucleotide molecule specifically bound to the first defined sequence segment of said heteropolymer.

Claim 6

The multimolecular complex of claim 3 wherein a selected activity of the non-oligonucleotide molecule specifically bound to the first defined sequence segment is modulated by hybridization of the second defined sequence segment of said heteropolymer.

Claim 7

The multimolecular complex of claim 3 wherein the affinity of the first defined sequence segment for the bound non-oligonucleotide molecule is modulated by hybridization of the second defined sequence segment of said heteropolymer.

Claim 8

A multivalent heteropolymeric hybrid structure comprising at least two synthetic heteropolymers, each synthetic heteropolymer being a single stranded nucleic acid molecule comprising at least a first and a second defined sequence segment, wherein said first defined sequence segment is not known to be a biological recognition site for nonoligonucleotide molecules and is capable of specifically and noncovalently binding to a non-oligonucleotide molecule and the second defined sequence segment being capable of hybridization.

Claim 9

A multivalent heteropolymeric hybrid structure comprising at least two synthetic heteropolymers, each synthetic heteropolymer being a single stranded nucleic acid molecule comprising at least a first and a second defined sequence segment, wherein said first defined sequence segment is not known to be a biological recognition site for nonoligonucleotide molecules and is capable of specifically and noncovalently binding to a non-oligonucleotide molecule and the second defined sequence segment being capable of hybridization.

Claim 10

The multivalent heteropolymeric hybrid structure of claim 6 wherein the second defined sequence segment of each synthetic heteropolymer comprises 5 to 40 nucleotides.

Claim 11

The multivalent heteropolymeric hybrid structure of claim 6 comprising two synthetic heteropolymers, each synthetic heteropolymer having a second defined sequence segment capable of hybridizing the two synthetic heteropolymers.

Claim 12

The multivalent heteropolymeric hybrid structure of claim 6 further comprising a linker oligonucleotide capable of hybridizing to the second defined sequence segment of each synthetic heteropolymer and joining the synthetic heteropolymers.

Claim 13

The multivalent heteropolymeric hybrid structure of claim 9 wherein the linker oligonucleotide comprises a duplex structure having single-stranded ends capable of hybridizing to the second defined sequence segments of the synthetic heteropolymers.

Claim 14

The multivalent heteropolymeric hybrid structure of claim 9 wherein the linker oligonucleotide comprises a triplex structure capable of hybridizing to the second defined sequence segments of the synthetic heteropolymers.

Claim 15

The multivalent heteropolymeric hybrid structure of claim 9 wherein the linker oligonucleotide comprises a branched-chain structure having defined sequence segments capable of hybridizing to the second defined sequence segments of the synthetic heteropolymers.

Claim 16

The multivalent heteropolymeric hybrid structure of claim 9 wherein the linker oligonucleotide comprises a circular structure having defined sequence segments capable of hybridizing to the second defined sequence segment of each synthetic heteropolymer.

Claim 17

A multimolecular complex comprising a multivalent heteropolymeric hybrid structure of claim 6 having a first non-oligonucleotide molecule specifically bound to the first defined sequence segment of the first synthetic heteropolymer of said heteropolymeric hybrid structure.

Claim 18

The multimolecular complex of claim 14 wherein the specific binding of the first non-oligonucleotide molecule to the first defined sequence segment of the first synthetic heteropolymer of said heteropolymeric hybrid structure modulates the affinity of the first defined sequence segment of a second synthetic heteropolymer of said heteropolymeric hybrid structure for a second non-oligonucleotide molecule.

Claim 19

The multimolecular complex of claim 14 wherein the specific binding of the first non-oligonucleotide molecule to the first defined sequence segment of the first synthetic heteropolymer of said heteropolymeric hybrid structure modulates a selected activity of a second, different non-oligonucleotide molecule specifically bound to the first defined sequence segment of the second synthetic heteropolymer of said heteropolymeric hybrid structure.

Claim 20

The multimolecular complex of claim 14 further comprising a second non-oligonucleotide molecule having a selected activity specifically bound to the first defined sequence segment of the second synthetic heteropolymer of said heteropolymeric hybrid structure.

Claim 21

A multivalent heteropolymeric hybrid structure comprising a first synthetic heteropolymer which is a single stranded nucleic acid molecule having at least a first and second defined sequence segment, wherein the first defined sequence segment is not known to be a biological recognition site for nonoligonucleotide molecules and is capable of specifically and noncovalently binding to a non-oligonucleotide molecule having a selected activity and wherein the second defined sequence segment is capable of hybridization, and a second synthetic heteropolymer which is a single stranded nucleic acid molecule having at least two defined sequence segments capable of hybridization.

Claim 22

A multivalent heteropolymeric hybrid structure comprising a first synthetic heteropolymer which is a single stranded nucleic acid molecule having at least a first and second defined sequence segment, wherein the first defined sequence segment is not known to be a biological recognition site for nonoligonucleotide molecules and is capable of specifically and noncovalently binding to a non-oligonucleotide molecule having a selected activity and wherein the second defined sequence segment is capable of hybridization, and a second synthetic heteropolymer which is a single stranded nucleic acid molecule having at least two defined sequence segments capable of hybridization.

Claim 23

A multimolecular complex comprising a synthetic heteropolymer of claim 1 having a first non-oligonucleotide molecule specifically bound to the first defined sequence segment of said heteropolymer.

Claim 24

The multimolecular complex of claim 19 wherein the specific binding of the first non-oligonucleotide molecule to the first defined sequence segment modulates the affinity of the second defined sequence segment of said heteropolymer for a second, different non-oligonucleotide molecule.

Claim 25

The multimolecular complex of claim 19 wherein the specific binding of the first non-oligonucleotide molecule to the first defined sequence segment modulates a selected activity of a second, different non-oligonucleotide molecule specifically bound to the second defined sequence segment of said heteropolymer.

Claim 26

The multimolecular complex of claim 19 further comprising a second non-oligonucleotide molecule specifically bound to the second defined sequence segment of said heteropolymer.